Calumet (CLMT) Stock Overview
Manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
CLMT Community Fair Values
Create NarrativeSee what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Calumet, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$37.37 |
| 52 Week High | US$36.94 |
| 52 Week Low | US$12.70 |
| Beta | 0.72 |
| 1 Month Change | 9.43% |
| 3 Month Change | 23.37% |
| 1 Year Change | 182.46% |
| 3 Year Change | 130.11% |
| 5 Year Change | 499.84% |
| Change since IPO | 71.82% |
Recent News & Updates
Narrative Update • May 14
CLMT: Shreveport Outage And Elevated Future P/E Will Pressure Returns
Analysts now hold Calumet's fair value steady at $25.00, with updated assumptions around discount rate, revenue growth, profit margins and future P/E shaping a more refined view of the stock's risk and earnings potential, rather than a change in the headline price target. What's in the News Calumet reported an operational update for the first quarter of 2026, highlighting unplanned maintenance at its Shreveport facility after organic chlorides were found in feedstock tanks (Key Developments).
Narrative Update • Apr 30
CLMT: Shreveport Restart And Higher Margin Outlook Will Support Bullish Case
Analysts have adjusted their price target on Calumet to $60.00. The latest update reflects revised views on discount rate, revenue growth, profit margins and future P/E assumptions.Narrative Update • Apr 15
CLMT: Shreveport Recovery And Improved Outlook Will Support Higher Future P/E
Analysts have lifted their fair value estimate for Calumet from $33.00 to $60.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple. What's in the News Calumet reported an operational update for the first quarter of 2026 after identifying organic chlorides in feedstock tanks at its Shreveport facility.Recent updates
Narrative Update • May 14
CLMT: Shreveport Outage And Elevated Future P/E Will Pressure Returns
Analysts now hold Calumet's fair value steady at $25.00, with updated assumptions around discount rate, revenue growth, profit margins and future P/E shaping a more refined view of the stock's risk and earnings potential, rather than a change in the headline price target. What's in the News Calumet reported an operational update for the first quarter of 2026, highlighting unplanned maintenance at its Shreveport facility after organic chlorides were found in feedstock tanks (Key Developments).Narrative Update • Apr 30
CLMT: Shreveport Restart And Higher Margin Outlook Will Support Bullish Case
Analysts have adjusted their price target on Calumet to $60.00. The latest update reflects revised views on discount rate, revenue growth, profit margins and future P/E assumptions.Narrative Update • Apr 15
CLMT: Shreveport Recovery And Improved Outlook Will Support Higher Future P/E
Analysts have lifted their fair value estimate for Calumet from $33.00 to $60.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple. What's in the News Calumet reported an operational update for the first quarter of 2026 after identifying organic chlorides in feedstock tanks at its Shreveport facility.Narrative Update • Apr 01
CLMT: Projected 2025 Losses And Rich P/E Will Pressure Future Returns
Analysts have kept their Calumet price target at $25.00, citing a slightly lower discount rate, more measured expectations for revenue growth and profit margins, and a higher assumed future P/E multiple as key inputs behind the unchanged valuation. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range between $69.0 million and $12.0 million based on preliminary data (Key Developments).Narrative Update • Mar 18
CLMT: Expected 2025 Losses Will Continue To Weigh On Returns
Analysts have raised their price target on Calumet from $19.00 to $25.00 per share, citing updated assumptions that include a lower discount rate, revised revenue growth expectations, higher profit margin estimates, and an adjusted future P/E multiple. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range between $69.0 million and $12.0 million (Key Developments).Narrative Update • Mar 04
CLMT: Lower Margin Assumptions And Expected 2025 Losses Will Restrain Returns
Narrative Update on Calumet The analyst fair value estimate for Calumet has been reset from $13.25 to $19.00. Analysts point to updated assumptions around discount rates, revenue growth, profit margins, and future P/E as key drivers of the new target range.
Narrative Update • Feb 18
CLMT: Expected 2025 Net Loss Will Sustain Bearish Equity Repricing
Analysts have nudged their price target on Calumet up by $0.80 to $23.45, reflecting updated assumptions around discount rates, profit margins and future P/E expectations. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, based on preliminary data (Key Developments).Analysis Article • Feb 05
Calumet, Inc. (NASDAQ:CLMT) Stock Rockets 26% But Many Are Still Ignoring The Company
Calumet, Inc. ( NASDAQ:CLMT ) shareholders have had their patience rewarded with a 26% share price jump in the last...Narrative Update • Feb 03
CLMT: Future Loss Guidance And Production Trends Will Support Fair Pricing
Analysts have raised their fair value estimate for Calumet from $21.45 to $22.65, citing updated assumptions around discount rates, revenue growth, profit margins and a future P/E of about 31.81x. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range of $69.0 million to $12.0 million based on preliminary data (Key Developments).Narrative Update • Jan 20
CLMT: Future Loss Guidance And Steady Production Will Support Fair Pricing
Analysts have kept their fair value estimate for Calumet steady at US$21.45, with only small tweaks to inputs such as the discount rate, revenue growth, profit margin and future P/E assumptions driving this unchanged price target. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range between $69.0 million and $12.0 million, based on preliminary data (Key Developments).Seeking Alpha • Jan 16
Calumet: Specialty Products' Businesses Coming Together Financially
Summary Calumet Specialty Products is executing a transformative strategy, with EBITDA projected to nearly double in 2026 and potentially triple by 2028. CLMT's integrated specialty, traditional refining, and renewable fuels businesses are aligning, supported by industry-leading cost structures and expanding SAF production capacity. We forecast 2026 EBITDA of $525–$550 million, up from $300 million in 2025, driven by SAF margin expansion and operational improvements. I rate CLMT a buy around $20, citing strong earnings growth potential, improving capital structure, and credible execution on renewables. Read the full article on Seeking AlphaNarrative Update • Jan 06
CLMT: Lower Margin Outlook Will Restrain Returns Despite Higher Production
Analysts have revised their price target on Calumet to US$13.25 from US$13.25, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E that reshape how they view the balance between the company’s earnings potential and the risk investors are taking on. What's in the News Calumet issued earnings guidance for the year ended December 31, 2025, indicating an expected net loss in a range of US$69.0 million to US$12.0 million, based on preliminary data (company guidance).Narrative Update • Dec 17
CLMT: Softer Margins And Slower Revenue Expansion Will Limit Upside Potential
Analysts have modestly trimmed their price target on Calumet to $13.25. This reflects slightly lower expectations for revenue growth and profit margins, even as a reduced discount rate and a marginally higher future P/E multiple continue to support the valuation.Narrative Update • Dec 03
CLMT: Future Profit Margins Will Improve While Shares Remain Fairly Valued
Analysts have nudged their price target on Calumet shares higher to reflect modestly improved discount rate and valuation assumptions, and now see fair value as essentially unchanged near 21.45 dollars despite slightly more favorable risk and earnings profiles. What's in the News Reported third quarter 2025 total facility production of 88,668 bpd, up from 83,305 bpd in the prior year period (company operating results announcement).Narrative Update • Nov 19
CLMT: Future Profit Margins Will Improve With Lower RIN Liabilities
Analysts have raised their price target for Calumet from $20.25 to $21.45, citing improved revenue growth projections and greater profit margin expectations as key drivers behind the updated valuation. What's in the News Calumet reported a rise in total facility production to 88,668 barrels per day for the third quarter of 2025, up from 83,305 barrels per day during the same period last year (Announcement of Operating Results).Narrative Update • Nov 05
CLMT: Future Outlook Balances EPA Exemptions With Reduced RIN Liabilities
Analysts have raised their price target for Calumet from $19.25 to $20.25, citing improved margin expectations and a lower perceived discount rate, even though growth forecasts have been slightly reduced. What's in the News Calumet received an update from the EPA confirming that all of its small refinery exemption petitions filed from 2019 through 2024 have been granted either full or partial exemptions (Key Developments).Narrative Update • Oct 22
Analysts Lift Calumet Price Target After EPA Exemptions and Stable Margin Outlook
Narrative Update on Calumet: Analyst Price Target Revision Analysts have slightly raised their fair value estimate for Calumet from $19.05 to $19.25 per share, citing minor improvements in discount rate assumptions and a stable outlook for profit margins. What's in the News Calumet received full or partial exemptions from the U.S. Environmental Protection Agency (EPA) for every small refinery exemption petition filed between 2019 and 2024.Narrative Update • Oct 08
Renewable Trends And Specialties Will Shape Future Markets
Analysts have maintained their price target for Calumet at $19.05. They cite only minor adjustments to discount rate and valuation assumptions that do not materially alter their outlook for the company.Narrative Update • Sep 24
Renewable Trends And Specialties Will Shape Future Markets
Calumet’s valuation outlook remains stable, with both the discount rate and future P/E changing only marginally, resulting in an unchanged consensus price target of $19.05. What's in the News Calumet received full or partial EPA exemptions on all small refinery petitions from 2019–2024, reducing its accrued RIN liability from 396 million to 89 million RINs. The company was added to multiple Russell indexes, including Russell 2000, 2500, 3000, and their respective growth and value variants, increasing its visibility to index funds and institutional investors.Analysis Article • Sep 11
The Market Lifts Calumet, Inc. (NASDAQ:CLMT) Shares 33% But It Can Do More
Calumet, Inc. ( NASDAQ:CLMT ) shareholders would be excited to see that the share price has had a great month, posting...Narrative Update • Sep 09
Renewable Trends And Specialties Will Shape Future Markets
Calumet’s valuation outlook remains steady, with both the discount rate and future P/E experiencing only marginal adjustments, resulting in the consensus analyst price target holding firm at $19.05. What's in the News EPA granted Calumet full or partial exemptions on all small refinery petitions from 2019–2024, reducing RIN liability from 396 million to 89 million RINs. Calumet was added to numerous Russell indexes, including Russell 2000, 2500, 3000, and related growth/value/small cap completeness benchmarks, increasing its visibility to institutional investors.Narrative Update • Aug 25
Renewable Trends And Specialties Will Shape Future Markets
Despite a notable increase in consensus revenue growth forecasts for Calumet, a decline in net profit margin offset the improvement, resulting in an unchanged analyst price target of $19.05. What's in the News Calumet added to multiple Russell indices, including the Russell 2000, 2500, and 3000, as well as corresponding Growth and Value subsets.Narrative Update • Aug 10
Renewable Trends And Specialties Will Shape Future Markets
Despite materially improving revenue growth and net profit margin forecasts, Calumet’s consensus analyst price target remains unchanged at $18.80. What's in the News Calumet, Inc.Analysis Article • Jul 18
Potential Upside For Calumet, Inc. (NASDAQ:CLMT) Not Without Risk
With a price-to-sales (or "P/S") ratio of 0.3x Calumet, Inc. ( NASDAQ:CLMT ) may be sending bullish signals at the...Analysis Article • Jun 14
Is There An Opportunity With Calumet, Inc.'s (NASDAQ:CLMT) 48% Undervaluation?
Key Insights Calumet's estimated fair value is US$29.23 based on 2 Stage Free Cash Flow to Equity Calumet is estimated...New Narrative • May 28
Sustainable Aviation Fuel Expansion Will Capture Future Market Opportunity
Accelerated renewables expansion and regulatory tailwinds drive higher margins, premium pricing, and stronger earnings outlook, particularly for sustainable aviation fuel and renewable diesel.Seeking Alpha • Apr 24
Calumet's Businesses Firing Like A Cannon, Well, Even Much Closer (Update)
Summary Calumet Specialty Products is significantly undervalued, with a misunderstood market and a heavy short position that is likely to face a destructive end soon. First-quarter EBITDA estimates are strong, with potential for $90 million, and second-quarter projections are even higher due to favorable market conditions. Management is effectively managing leverage and cash flow, aiming to reduce debt significantly while maintaining positive cash flow and strong EBITDA generation. Despite risks from shorting and market uncertainties, the company's strategic moves and financial performance suggest a bullish outlook, making it a compelling buy. Read the full article on Seeking AlphaAnalysis Article • Apr 17
It's Down 29% But Calumet, Inc. (NASDAQ:CLMT) Could Be Riskier Than It Looks
Unfortunately for some shareholders, the Calumet, Inc. ( NASDAQ:CLMT ) share price has dived 29% in the last thirty...Seeking Alpha • Mar 11
Calumet's Businesses Firing Like A Cannon, Well, Close
Summary Calumet delivered in-line Q4 2024 results, with management's asset sales and cash generation efforts creating a favorable buying opportunity. Specialty EBITDA is projected to improve to the low $200 million range in 2025, driven by stronger Gulf Coast 2-1-1 spreads and operational efficiencies. The partial sale of Performance Brands for $110 million will be offset by operational efficiencies, maintaining EBITDA levels over the next two years. Montana Renewables' cost structure improvements and strategic expansions position it as a low-cost producer, with significant cash flow contributions expected to support debt reduction and growth initiatives. Read the full article on Seeking AlphaAnalysis Article • Feb 04
Calumet, Inc. (NASDAQ:CLMT) Could Be Riskier Than It Looks
Calumet, Inc.'s ( NASDAQ:CLMT ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now...Seeking Alpha • Jan 13
Update On Calumet, My Largest Investment
Summary Calumet, Inc. is undervalued and misunderstood, potentially reaching $30-$40 per share. The company’s Montana Renewables business reprocesses renewable feedstock into sustainable aviation fuel and renewable diesel, attracting ESG investors. Calumet secured $1.67 billion from the Department of Energy for its renewable fuels facility, enhancing its balance sheet and future expansion. Consider buying CLMT equity and writing January 2026 $30 calls to defer taxes to long-term capital gains in 2026. Read the full article on Seeking AlphaAnalysis Article • Jan 12
The Returns On Capital At Calumet (NASDAQ:CLMT) Don't Inspire Confidence
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...Seeking Alpha • Nov 17
Long-Term Investing In Calumet Specialty Products
Summary Investors should maintain a long-term vision despite short-term market fluctuations, as patience is crucial for substantial returns. Examples like Cirrus can help Calumet investors navigate investment strategies. The marketplace today requires a focus on 2-year, 5-year, and 20-year investment horizons to navigate risks effectively. Investors often get cranky during ugly years, but staying the course is essential for achieving long-term financial goals. Read the full article on Seeking AlphaAnalysis Article • Nov 11
Is There An Opportunity With Calumet, Inc.'s (NASDAQ:CLMT) 26% Undervaluation?
Key Insights The projected fair value for Calumet is US$29.95 based on 2 Stage Free Cash Flow to Equity Current share...Analysis Article • Oct 16
There's No Escaping Calumet, Inc.'s (NASDAQ:CLMT) Muted Revenues Despite A 28% Share Price Rise
Calumet, Inc. ( NASDAQ:CLMT ) shares have continued their recent momentum with a 28% gain in the last month alone. The...Shareholder Returns
| CLMT | US Oil and Gas | US Market | |
|---|---|---|---|
| 7D | 9.7% | 0.1% | 1.2% |
| 1Y | 182.5% | 30.6% | 27.0% |
Return vs Industry: CLMT exceeded the US Oil and Gas industry which returned 30.6% over the past year.
Return vs Market: CLMT exceeded the US Market which returned 27% over the past year.
Price Volatility
| CLMT volatility | |
|---|---|
| CLMT Average Weekly Movement | 6.4% |
| Oil and Gas Industry Average Movement | 6.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CLMT has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CLMT's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 1,540 | Louis Borgmann | www.calumet.com |
Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments. The Specialty Products and Solutions segment manufactures and markets various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products.
Calumet, Inc. Fundamentals Summary
| CLMT fundamental statistics | |
|---|---|
| Market cap | US$3.15b |
| Earnings (TTM) | -US$188.80m |
| Revenue (TTM) | US$4.17b |
0.8x
P/S Ratio-17.2x
P/E RatioIs CLMT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLMT income statement (TTM) | |
|---|---|
| Revenue | US$4.17b |
| Cost of Revenue | US$3.92b |
| Gross Profit | US$255.80m |
| Other Expenses | US$444.60m |
| Earnings | -US$188.80m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.17 |
| Gross Margin | 6.13% |
| Net Profit Margin | -4.52% |
| Debt/Equity Ratio | -314.6% |
How did CLMT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/03 21:36 |
| End of Day Share Price | 2026/06/03 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Calumet, Inc. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Richard Gross | Barclays |
| Conor Fitzpatrick | BofA Global Research |
| Jennifer Fitzpatrick | BofA Global Research |